Meet Inspiring Speakers and Experts at our 3000+ Global Events with over 1000+ Conferences, 1000+ Symposiums and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series : World’s leading Event Organizer

Conference Series Conferences gaining more Readers and Visitors

Conference Series Web Metrics at a Glance

  • 3000+ Global Events
  • 100 Million+ Visitors
  • 75000+ Unique visitors per conference
  • 100000+ Page views for every individual conference

Unique Opportunity! Online visibility to the Speakers and Experts

Renowned Speakers

Thomas W. Kozlowski

Thomas W. Kozlowski

Associate Director of Operations Joint Commission International Singapore

Jianhua Luo

Jianhua Luo

Professor and Director University of Pittsburgh USA USA

Anghel Adrian Udrea

Anghel Adrian Udrea

American Society for Radiation Oncology Romania

Recommended Global Oncology & Cancer Webinars & Conferences

Europe & UK

Asia Pacific & Middle East

Canada

Cancer Care 2023

About Conference


Conference Series greets you to attend “15th Annual Conference on Cancer Research" which is going to be held on September 21-22, 2023 at Kualalumpur, Malaysia. We heartily invite all the participants interested in sharing their knowledge and research in Cancer Research.

15th Annual Conference on Cancer Research is mainly based on the theme “Current Perspectives and New Challenges in Cancer Research and Therapy.

Why to Attend?

The CANCER CARE 2023 welcomes individuals over the globe concentrated on learning out about cancer science application and its specialities. This is the absolute best chance to achieve great number of participants. Sharing the information, data and B2B meetings with industrialists and potential customers to make a sprinkle with imaginative items live and mark acknowledgment at this occasion. Widely acclaimed speakers, the latest systems, and the most recent updates in Cancer science are the best signs of this meeting. It also provides the way for huge range of Oncologists to interact with one another.

CANCER CARE 2023 provide Oncologists, radiologists, practitioners and educators a platform where they can put their education, training, and skills to valuable use and can discuss the most recent innovations, and practical challenges, encountered and solutions adopted in the field of Cancer science and Therapy. Cancer research universities in Asia-pacific regions, under a single solitary rooftop, in this way give every one of them a stage to share information and the different scientific headways of the current circumstances, in the field of Cancer and aides in empowering future research exercises. It is the one among the best platform to discuss the innovative researches and developments in the field of cancer science and therapy.

Target Audience:

  • Oncologists
  • Radiologists
  • Immunologists
  • Clinical Researchers
  • Nursing
  • Malignancy Researchers
  • Researchers
  • Biomarker Associations and Societies
  • Business Entrepreneurs
  • Preparing Institutes
  • Programming creating organizations
  • Information Management Companies
  • Pharmaceutical Companies
  • Diagnostics Companies

Scientific Sessions

Track 01 : Cancer Science

Cancer Science is an in depth field that deals with cancer analysis and medical aid. Cancer, once thought-about as a deadly wellness, however currently with a development within the cancer analysis things has modified. They changes square measure typically the results of changes to the deoxyribonucleic acid among the cells. A Thought-about it’s thought-about as a large success as there are unit totally different therapies obtainable currently to treat and diagnose the cancer. The targeted cancer medical aid is one among the best therapies in treating cancer because it involves the treating of the cancer cells by targeting and inhibiting the precise molecules that area unit would like for the growth progression.

Related Topics: Cancer Cell Biology | Oncogenes | Tumor Immunology | Hematology | Viral therapy | Stemcell research | Stem cell Transplantation

Track 02 Organ Specific Cancer

Organ specific Cancer depends on the area of disease cells happen specifically organ. There are more than 200 different types of cancer diagnosed. Among them, Lung cancer, breast cancer is the most common cancer diagnosed in 2015. Apart from this prostate cancercolon cancers, bladder cancer, breast cancer are the most common type cancer. The rare types of cancers are which affect the bone known as Bone Cancer. Depending upon the location of cancer the causes, symptoms, and method of treatments vary. Carcinoma, Sarcoma,  leukaemia, lymphoma, and melanoma are the types of cancer found in different organs.

Related Topics: Cancer Cell Biology | Oncogenes | Tumor Immunology | Hematology | Viral therapy | Stemcell research | Stem cell Transplantation

Track 03 : Cancer Genetics and Epigenetics

Risk expectation and prediction and Cancer prevention, growth counteractive action is also promising and encouraging areas of Epigenetics. A high adequacy of demethylating agents were accounted for essentially in hematological malignancies in view of new conventions with low dose and long exposure, and their utilization is presently being striven for strong tumors. During the cell’s transformation to Cancerous cell, Epigenetic modifications are also more important like genetic mutation. Their manipulation brings a great promising approach for inventing, detecting and treatment of cancer.

Related Topics: Cancer Cell Biology | Oncogenes | Tumor Immunology | Hematology | Viral therapy | Stemcell research | Stem cell Transplantation

Track 04 : Cancer Bioinformatics

Cancerbioinformatics is another interdisciplinary region including organic, measurable and computational sciences. Now a day’s bioinformatics innovation is for the most part utilized for the special growth investigation. Ribosomal S6 protein kinase 4 (RSK4) is a vital novel tumor silencer that hinders breast cancer cell development and initiates senescence. Utilizing pair proclivity cleaning, we got protein buildings that associated with RSK4 or RSK4m. Mass range examination was performed to distinguish the acquired protein edifices, and bioinformatics investigation was performed.

Related Topics : Cancer Cell Biology | Oncogenes | Tumor Immunology | Hematology | Viral therapy | Stemcell research | Stem cell Transplantation

Track 05 : Radiation Therapy

Radiation therapy occurs in the presence of biochemical recurrence after prostatectomy to assess whether this results in shifts of histopathological prognostic factors such as the Gleason Score using ionizing radiation  in the treatment of cancer. The field of radiation oncology covers the integration of radiation therapy into multimodal treatment approaches. Radiation Oncology provides an open access forum for researchers and clinicians involved in the management and treatment of cancer patients, bringing together the latest research and advances in the field. The types of radiation therapy are:

Related Topics : Cancer Cell Biology | Oncogenes | Tumor Immunology | Hematology | Viral therapy | Stemcell research | Stem cell Transplantation

Track 06 Chemotherapy

Chemotherapy damages cells as they divide. In the centre of each living cell is the nucleus, this is the control centre of the cell. It contains chromosomes, which are made up of genes. These genes have to be copied exactly each time a cell divides into 2 to make new cells. Traditional chemotherapeutic agents are cytotoxic by means of interfering with cell division but cancer cells vary widely in their susceptibility to these agents. To a large extent, chemotherapy can be thought of as a way to damage or stress cells. These include rheumatoid arthritis, systemic lupuserythematosus, multiplesclerosis, vasculitis and many others alkylatingagents, plantalkaloids, antimetabolites, anthracyclines, topoisomerase inhibitors and corticosteroids.

Related Topics: Cancer Cell Biology | Oncogenes | Tumor Immunology | Hematology | Viral therapy | Stemcell research | Stem cell Transplantation

Track 07 : Tumor Invasion and Metastasis

Tumor Invasion and Metastasis theme of the Department of Cancer Biology aim to expand translational research on the processes that enable tumor cells to invade surrounding tissues, disseminate through the body and colonize distant organs. Metastasis is responsible for the majority of cancer-associated deaths. By developing treatment approaches that target invasion and metastasis, we aim to significantly reduce cancer mortality. This is a largely unexplored area for the development of novel therapeutic drugs because the molecular mechanisms that mediate cancer invasion and metastasis are still poorly understood.

Related Topics: Cancer Cell Biology | Oncogenes | Tumor Immunology | Hematology | Viral therapy | Stemcell research | Stem cell Transplantation

Track 08 Nanotechnology In Cancer

Nanotechnologies are also being investigated to deliver immunotherapy. Standalone nanoparticle vaccines are also being designed to raise sufficient T cell response to eradicate tumors, through co-delivery of antigen and adjuvant, the inclusion of multiple antigens to stimulate multiple dendritic cell targets, and continuous release of antigens for prolonged immune stimulation. Molecular blockers of immune-suppressive factors produced can also be co-encapsulated in nanoparticle vaccines to alter the immune context of tumors and improve response, an approach being pursued in the Nano Approaches to Modulate Host Cell Response for Cancer Therapy Center at UNC.

Related Topics: Cancer Cell Biology | Oncogenes | Tumor Immunology | Hematology | Viral therapy | Stemcell research | Stem cell Transplantation

Track 09 : Gastric Cancer stem cells

Gastricepithelium is continuously regenerated by gastric stem cells, which give rise to various kinds of daughter cells, including parietal cells, chief cells, surface mucous cells, mucous neck cells, and enter endocrine cells. Recently, it was hypothesized that cancer stem cells drive the cancer growth and metastasis. In contrast to conventional clonal evolution hypothesis, only cancer stem cells can initiate tumor formation, self-renew, and differentiate into various kinds of daughter cells. we review here how critical signaling pathways, including hedgehogWantNotch, epidermal growth factor, and bone morphogenetic protein signaling, may regulate the self-renewal and differentiation of gastric stem cells and gastric cancer stem cells.

Related Topics: Cancer Cell Biology | Oncogenes | Tumor Immunology | Hematology | Viral therapy | Stemcell research | Stem cell Transplantation

Track 10 : Biomarkers of Cancer Stem Cells

Biomarkers have a particularly high top side for therapeutic interventions in cancer patients. Most cancer biomarkers contains proteins or altered segments of deoxyribonucleic acid, and area unit expressed altogether cells, simply at higher rates in cancer cells.These growth biomarkers are accustomed track the health of tumors, however cannot function the only real diagnostic for specific cancers. Samples of tumoral markers accustomed follow up cancer treatment are the Carcinoembryonic antigen (CEA) for large intestine cancer and therefore the Prostate Specific antigen (PSA) for glandular cancer. In 2014, Cancer analysis known current growth Cells  and current growth DNA as metastasizing growth biomarkers with special cellular differentiation and prognostic skills

Related Topics: Cancer Cell Biology | Oncogenes | Tumor Immunology | Hematology | Viral therapy | Stemcell research | Stem cell Transplantation

Market Analysis

Global market is segmented into Europe, North America, Latin America, Asia pacific, and Middle East and Africa. According to market study, Market Value for Oncology will be more than double to $ 623 Million by 2020. A major part of research is going on the top Universities on across the globe. Many companies are associated with various Cancer Screening and Diagnostics instruments and other therapeutics. Besides this various societies, associations and research centre are also associated in this research field.

As per 2012 insights around 14.1 million cases are passed on and 8.2 million deaths are accounted for. Lung, Brain, Stomach and bowel malignancies cause the most widely recognized deaths among the worldwide that records almost 60% of all the cancer deaths. In males 5 most regular sites of malignancy are recognized in 2014 were lung, prostate, colorectal and liver diseases. In females 5 most shared locales analyzed were bosom, Ovary and stomach tumour

Past Conference Reports

World Oncology 2022 :

With the immense support of Organizing Committee we successfully hosted the “9th World Summit on Cancer Science and Oncology” was held during May 26, 2022. Conference theme “Exploring the Research Ideas in Oncology and Cancer Research”.

On behalf of Organizing Committee we express our gratitude towards those who helped this conference to be successful one. We are very thankful to all the Attendees, delegates, keynote speakers, plenary speakers, business partners, poster presenter, moderators, chair and co-chair from around the globe. The conference gave the attendees a pleasant ride through the recent advancement and new technologies delivered for the Cancer Science and Oncology. This conference was thankful to its moderators: Jessica Christi.

Cancer Meeting Summit 2021 :

Experts Meeting on Cancer Medicine, Radiology & Treatment  on  June 29-302020 AthensGreece. Global cancer congress has gotten a prosperous reaction from everywhere throughout the world. This has been sorted out with the point of Cancer Prevention, Diagnosis, and Treatment of sicknesses of the Organ-related Cancers and its imaginative techniques

The prominent characters at the gathering were :

 Jana Slobodnikova Alexander , Dubcek University of Trencin, Slovakia

 Prof ihab ahmed ,Cairo University, Egypt

 Barbara DeVivo , Westmont University, USA

 Dr. Jehad Zweiri  ,University of Liverpool, UK

Cancer Science 2020 :

40th Euro Congress on Cancer Science & Therapy was organized on May 25-26, 2020 at RomeItaly. Cancer Science 2020 Congress has received a generous response from all over the world. This has been organized with the aim of endorsing the development of new perceptions and ideas for investigating the high level of knowledge reached by scientific community on Cancer Science and Therapy.

 The conference was organized around the theme “Strengthening the future to fight against cancer”. The congress entrenched a firm relation of future strategies in the field of Cancer Science with the scientific community. This congress brought together  the Leading physicians, surgeons, Clinicians, Professors, Care Specialists, Students and other professionals in which many issues in Oncology field were discussed in depth to provide up-to-date information to the world. On the other hand, the meeting provided an opportunity for networking.

The eminent personalities at the conference were:

Sang Youn Hwang, Dongnam Institute of Radiological & Medical Sciences, Korea

Zheng Wu, Capital University of Physical Education and Sports, China

Eleni Petsalaki , University of Crete, Greece

Global Cancer 2019 :

Global Cancer 2019 is distinguished by the presence of members of the editorial board of journals, scientists, young researchers, trade commissioners, and student communities supported representing more than 25 countries that have made this conference rewarding and fruitful. Our “3rd Global summit on oncology and Cancer”  scheduled for May 06 to 072019 at the Radisson Hotel Narita in TokyoJapan, was based on the theme “New chemotherapeutic approaches for treatment of cancer” which has encrusted the below scientific sessions:

  • Radiation Oncology
  • Cancer & Stem Cell Therapy
  • Surgical Oncology
  • Cancer Immunotherapy
  • Cancer Cell Biology and Genetics

To Collaborate Scientific Professionals around the World

Conference Date September 21-22, 2023

For Sponsors & Exhibitors

sponsor@conferenceseries.com

Speaker Opportunity

Past Conference Report

Supported By

Cancer Science & Therapy Journal of Cancer Diagnosis

All accepted abstracts will be published in respective Conference Series International Journals.

Abstracts will be provided with Digital Object Identifier by